enGene Holdings share price logo

enGene Holdings

NASDAQ: ENGN

$1.66

-0.06

(-3.49%)

Live

as on

enGene Holdings Stock Performance

as on November 6, 2026 at 5:07 am IST

  • Day's High

    $1.66
    $1.71

    3.01%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.40
    $12.25
    downward going graph

    15.66%

    Downside

    637.95%

    Upside

    downward going graph

enGene Holdings share price movements today

Previous Close
$1.72
Open
$1.69
Volume
597.9K
Market Cap
$97.2M
Day's Low - High
$1.66 - $1.71
52 Week Low - High
$1.40 - $12.25

enGene Holdings Historical Returns

1 Month Return
-8.02 %
3 Month Return
-4.44 %
1 Year Return
-72.87 %
3 Year Return
-86.88 %
5 Year Return
0 %

enGene Holdings Stock Fundamentals & Key Indicators

Check enGene Holdings market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$97.2M

EPS (TTM)

-0.28

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-5.79

Industry PE ratio

-2.49

PEG Ratio

-0.06

EBITDA

-131.9M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-2.10%

enGene Holdings vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of enGene Holdings with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Neutral$97.2MNA-5.790.00%0.00%
Neutral$91.2B9.03%-28.63-12.57%0.00%
StrongBuy$141.7B192.56%32.2786.04%0.00%
Buy$99.4B52.18%20.7385.77%0.38%

Stock Returns calculator for enGene Holdings Stock including INR - Dollar returns

The enGene Holdings stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

enGene Holdings investment value today

Current value as on today

₹27,933

Returns

-₹72,067

(-72.07%)

Returns from enGene Holdings Stock

-₹73,817 (-73.82%)

Dollar Impact

₹1,750 (+1.75%)

Analyst Recommendation on enGene Holdings Stock

Based on 4 analysts

HOLD

25.00%

Buy

75.00%

Hold

0.00%

Sell

Based on 4 analysts, 75% of analysts recommend a 'HOLD' rating for enGene Holdings. Average target price of $3.29

enGene Holdings Share Price Target

Get share price movements and forecasts by analysts on enGene Holdings.

What analysts predicted

49.54%UPSIDE

Target Price

$3.29

Current Price

$1.66

Analyzed by

4 Analysts

High

$4

Target

$3.29

Low

$2

enGene Holdings target price $3.29, a slight upside of 49.54% compared to current price of $1.66. According to 4 analysts rating.

Indian Investors' Interest in enGene Holdings Stock

Search interest for enGene Holdings Stock has decreased by -30% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-30% versus previous 30 day period

enGene Holdings Quarterly Profit & Loss

All numbers in Millions USD

Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
-
-
-
-
-
-
0
0
0
Operating Income
-17
-16
-17
-26
-27
-29
-39
-31
31
34
EBITDA
-14
-13
-14
-23
-24
-27
-37
-28
-31
-33
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-14
-14
-15
-24
-25
-28
-38
-29
30
32
Income Tax Expense
0
0
0
0
0
0
0
-
-
-
Net Income
-14
-14
-15
-24
-25
-28
-37
-29
30
32
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

enGene Holdings Annual Profit & Loss

All numbers in Millions USD

Oct 2021
Oct 2022
Oct 2023
Oct 2024
Oct 2025
Total Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Income
-15
-19
-26
-62
-123
EBITDA
-18
-22
-94
-52
-113
Interest Expense
5
1
4
2
2
Depreciation
0
0
0
0
0
Income Before Tax
-23
-24
-99
-55
-117
Income Tax Expense
-
0
0
0
-
Net Income
-23
-24
-99
-55
-117
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%

enGene Holdings Quarterly Cash Flow

All numbers in Millions USD

Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Net Income
-14
-14
-15
-24
-25
-28
-37
-29
-30
-32
Operating Cash Flow
-14
-7
-19
-25
-22
-25
-24
-28
-30
-18
Investing Cash Flow
0
0
-125
-84
17
1
40
-126
23
30
Financing Cash Flow
193
0
60
0
0
0
1
141
0
0
Change in Cash
179
-7
-84
-110
-4
-24
17
-13
-6
11

enGene Holdings Annual Cash Flow

All numbers in Millions USD

Oct 2021
Oct 2022
Oct 2023
Oct 2024
Oct 2025
Net Income
-23
-24
-99
-55
-117
Operating Cash Flow
-15
-17
-24
-48
-99
Investing Cash Flow
0
0
0
-125
-25
Financing Cash Flow
22
27
86
265
1
Change in Cash
6
9
61
91
-122

Global Institutional Holdings in enGene Holdings

Check out the Institutions with significant holdings in enGene Holdings.

Funds
Holdings
Joseph Edelman
7.20%
Gerald Brunk
4.26%
Otello Stampacchia
1.31%
Michael Rockefeller
0.37%
ANTHONY TZEYEW CHEUNG
0.15%

enGene Holdings News & Key Events

  • img

    Today's Timeline - 11 November

    Tue, 09:07 PM

    -

    enGene reports promising Phase 2 trial data, leading to a 64.73% stock increase.

Insights on enGene Holdings

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ENGN stock has moved up by 12.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 233.3% return, outperforming this stock by 320.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 996.7% return, outperforming this stock by 1069.6%

About enGene Holdings

Operating through its subsidiary, enGene, Inc., enGene Holdings Inc. functions as a clinical-stage biotechnology firm. Its core mission involves pioneering genetic pharmaceuticals, achieved by administering therapeutic agents directly to mucosal tissues and other bodily organs. A key asset in its pipeline is EG-70, also known as detalimogene voraplasmid. This innovative non-viral immunotherapy is being developed to treat non-muscle invasive bladder cancer in patients diagnosed with carcinoma-in-situ (Cis) who have shown no improvement after Bacillus Calmette-Guérin therapy. The company was established in 2023 and is headquartered in Saint-Laurent, Canada.
OrganisationenGene Holdings
Headquarters4868 Rue Levy, Montreal, QC, H4R 2P1, CA
IndustryBiotechnology
CEORonald H. W. Cooper

Key Management of enGene Holdings

Name

Title

Ms. Kathleen Richton

Senior VP of Finance, Principal Accounting & Financial Officer and Controller

Ms. Tara Place M.B.A.

Senior VP of Human Resources

Mr. Matthew Boyd

Chief Regulatory Officer

Mr. Ronald H. W. Cooper

President, CEO & Director

Ms. Joan Connolly

Chief Technology Officer

Dr. Anthony T. Cheung Ph.D.

Consultant

Ms. Jill Buck

Chief Development Officer

Ms. Amy Pott

Chief Global Commercialization Officer

Dr. William J. Grossman M.D., Ph.D.

Interim Chief Medical Officer & Director

FAQs

What is enGene Holdings share price today?

enGene Holdings share price today is $1.66 as on . enGene Holdings share today touched a day high of $1.71 and a low of $1.66.

What is the 52 week high and 52 week low for enGene Holdings share?

enGene Holdings share touched a 52 week high of $12.25 on and a 52 week low of $1.40 on . enGene Holdings stock price today i.e. is trending at $1.66,which is 86.45% down from its 52 week high and 18.57% up from its 52 week low.

What is enGene Holdings's market capitalisation today?

enGene Holdings market capitalisation is $0.00T as on .

How to invest in enGene Holdings Stock (ENGN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for enGene Holdings on INDmoney app. Click on Buy button.

What is the minimum amount required to buy enGene Holdings Stock (ENGN) from India?

Indian investors can start investing in enGene Holdings (ENGN) shares with as little as ₹94.4749984741211 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.75 in enGene Holdings stock (as per the Rupee-Dollar exchange rate as on ). Based on enGene Holdings share’s latest price of $1.66 as on November 5, 2026 at 11:37 pm IST, you will get 6.0241 shares of enGene Holdings. Learn more about fractional shares .